Trading in Sino Biopharmaceutical shares halted after stock plunges
HONG KONG, Sept 12
HONG KONG, Sept 12 (Reuters) - Trading in shares of Chinese medicine maker Sino Biopharmaceutical Ltd was suspended on Thursday, pending a statement, according to data from the Hong Kong stock exchange.
No further details were immediately available.
Officials from the company were not immediately available for comment.
The stock plunged as much as 24.9 percent to HK$4.28 on Thursday morning, their lowest since February 27. The shares were down 16.5 percent prior to the suspension.
That was compared to a 0.24 percent gain in the benchmark Hang Seng Index.
(Reporting by Donny Kwok; Editing by Anne Marie Roantree)
- Air strike kills 15 civilians in Yemen by mistake: officials
- North Korea executes leader's powerful uncle in rare public purge |
- Insight: In Yemen, al Qaeda gains sympathy amid U.S. drone strikes
- Storm to cloak Midwest to Northeast in snow, freezing rain
- Twitter backtracks on block feature after users revolt |